ContraFect Announces Presentation at the International Society of Cardiovascular Infectious Diseases Symposium

NEXT STORY
Myriad Genetics Announces New Results from Two Large Studies of Its myRisk® Hereditary Cancer Test at American Society of Clinical Oncology
PREV STORY
Oncology Venture receives response from the FDA to the IND-application and proposed pivotal study for LiPlaCis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Presents Additional Positive Data from the Phase 2 Trial of Exebacase at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

author_avatar
NASDAQ Market News

Global Flow Cytometry Market is Expected to Reach USD 8.59 Billion by 2025 : Fior Markets

author_avatar
NASDAQ Market News

Sorrento Board Rejects Latest Acquisition Proposal

author_avatar
NASDAQ Market News